Hey ken, whose getting fired for this?

Quote












I'm guessing Ken will think that over as he cashes in his $15MM this year. He's obviously worth every penny of that…it takes a real genius to get rid of 20,000 employees while earning $15MM per year to screw all of those people over.

Thanks, as swipe.
 




Anonymous said:
I'm guessing Ken will think that over as he cashes in his $15MM this year. He's obviously worth every penny of that…it takes a real genius to get rid of 20,000 employees while earning $15MM per year to screw all of those people over.

Thanks, as swipe.
Click to expand...
You are not an employee, you are a liability that must be purged!
 




Anonymous said:
I'm guessing Ken will think that over as he cashes in his $15MM this year. He's obviously worth every penny of that…it takes a real genius to get rid of 20,000 employees while earning $15MM per year to screw all of those people over.

Thanks, as swipe.
Click to expand...

You shouldn't take this personally. It is just business. Remember, Ken doesn't answer to you. The CEO and BoD only answer to the shareholders.

This is the new business model~besides corporations are people too. And the corporation needs to make money.

You (as are most of the employees) just a liability/expense in a column on a ledger sheet.
 
















































Anonymous said:
What a blissful Christmas this will be knowing that it's been a year since leaving this shell of a company. Greener pastures truly do exist. I feel good!
Click to expand...
Very blissful. Is that why you are here on a Friday night at 8:36 PM. If it was so blissful you would be with family. You don't even work here anymore.

I feel bad for you.
 




Anonymous said:
Out maneuvered and bested in negotiations by Mr. Bonney. It seems Mr. Frazier skills as an attorney did not serve Merck well. Otherwise, everybody should calm down because nobody is getting fired over this boondoggle. This remains true regardless of the FDA decisions about Zerbaxa.
Click to expand...

The play for Zerbaxa seems to have worked out with the FDA approval.
http://news.yahoo.com/fda-approves-...ic-resistant-bacteria-231237277--finance.html

Just not sure it is going to pay off.
"Zerbaxa is expected to reach peak sales of $1.15 billion in 2023 and will be priced around $5,000-$6,000 per patient, analysts including Koffler said."
 








Top Bottom
Back
Quote